Exploring Acne Treatments Through Clinical Research Participation
Part of paid clinical trials in San Francisco, California.
- Sponsor
- Power Life Sciences Inc.
- Study ID
- NCT07010458
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Acne
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
The purpose of this study is to understand the lived experiences of acne patients enrolled in a related clinical trial testing a particular treatment. The primary focus will be on tracking trial adherence and dropout rates to enhance future research and care approaches, especially for underserved groups.
Key Dates
- Start date
- Jun 30, 2026
- Status verified
- May 2025
- Primary completion
- Jun 30, 2027
- Completion
- Jun 30, 2028
Study Design
- Enrollment
- 500 participants (estimated)
Primary Outcome Measure
Rate of patients who decide to enroll in an acne clinical research. [ Time Frame: 3 month ]
Central Contacts
- Michael B Gill(415) 900-4227
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Power Life Sciences | San Francisco | California | 94107 | - |
Find similar trials in San Francisco, CA
By research site
Related Studies
- The Use of Image-Based Computer Gradings in the Analysis of Acne, Rosacea, Melasma, and Seborrheic DermatitisRecruiting · Integrative Skin Science and Research · Sacramento, California
- Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe AcnePHASE1/PHASE2 · Recruiting · Sanofi Pasteur, a Sanofi Company · Scottsdale, Arizona
- Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Participants With Mild AcnePHASE1/PHASE2 · Recruiting · Sanofi Pasteur, a Sanofi Company · Encino, California
- A Full Face Study to Evaluate the Efficacy of Dermapen 4™ Microneedling Device in Addition with MG-CLR Serum for Acne Treatment Over 12 Weeks.PHASE2/PHASE3 · Not Yet Recruiting · Equipmed USA LLC · Birmingham, Alabama